The Michigan Prostate Score (MiPS; Mlabs, Ann Arbor, MI, USA) combines sPSA with the mRNA expression of two PCa-specific urinary markers Prostate Cancer Antigen 3 (PCA3) and Transmembrane Serine Protease 2 (TMPRSS2)—ETS-related gene (ERG) gene fusion (T2-ERG) to predict the risk of PCa and PCa GS ≥ 7. Here, ERG is linked to posterior cortical atrophy.